Radiopharmaceutical provider IBA Molecular has created two centers for innovation designed for advanced radiopharmaceutical contract development and manufacturing. The centers are located in Totowa and Somerset, New Jersey.
Both centers are expected to contribute to the development of a new generation of disease-specific tracers and companion theranostic products.
The primary radiopharmaceutical facility in Totowa is an 8,500-sq-ft research and development center staffed with radiochemists, nuclear pharmacists, quality control chemists, and cyclotron engineers.
